Sep 11, 2023 - Sep 14, 2023 / 12:40PM GMT
Thibault Boutherin - Morgan Stanley, Research Division - Equity Analyst
So good morning, everyone. Thank you for joining this session of the Morgan Stanley Global Healthcare Conference. My name is Thibault Boutherin. I am part of the Pharma Equity Research team based in London.
Before we start this session, I just need to refer to important disclosures. Please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So for this session, I'm delighted to have with me Richard Francis, CEO of Teva. Thank you for joining us today. So we will shortly start the Q&A. And I invite investors in the room who have any questions to raise their hand for the session, and we'll get a mic to you.
But before we start, Richard, we'd like to start with some introductory comments on the current situation and outlook for Teva.
Richard D.
Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers